Colorectal cancer deaths are declining, but shocking regional, racial and ethnic disparities remain. According to the American Cancer Society, Latinos in the United States are more likely to die from ...
Read more https://www.kxan.com/news/simplehealth/new-blood-test-for-colon-cancer-offers-less-invasive-option-hopes-to-increase-early-detection/ There is a new and less invasive option to test for ...
Forbes contributors publish independent expert analyses and insights. A physician who writes about challenges with navigating healthcare. And while colonoscopy remains the gold standard for prevention ...
Scientists have developed a five-variable index aimed at identifying which individuals in the average-risk spectrum for advanced colorectal neoplasia (ACN) can skip colonoscopy in favor of less ...
Money Talks News on MSN
This at-home test detects cancer as effectively as a colonoscopy
FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...
Colorectal cancer diagnoses are increasing in people younger than age 50, with a significant portion expected in the next decade. Regular screenings, particularly colonoscopies, are crucial for early ...
Just hearing the word “colonoscopy” can make anyone grimace — but it can also save your life. In the United States, colorectal cancer is the third most common cancer in both men and women, and the ...
El Paso Police search for missing 72-year-old man with Alzheimer's Authorities are searching for Guadalupe Perez Ramirez, a 72-year-old man diagnosed with Alzheimer's disease, who went missing on Jan.
Patients undergoing laparoscopic colorectal surgery had fewer clotting complications than patients with open colorectal surgeries, according to a report in the Archives of Surgery. In a broad study ...
The Cologuard Plus test is more accurate than the original Cologuard, and should be easier to mail in for stool analysis. The newest version of Cologuard, an at-home colon cancer screening test, ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--COLOTECT™ 3.0 is a non-invasive colorectal cancer screening test developed by BGI, and will be launched in early 2023. BGI plans to release pre-clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback